TPSB2 p.Val76Leu

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_024164.6(TPSB2):​c.226G>T​(p.Val76Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Benign in ClinVar.

Frequency

Genomes: not found (cov: 18)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

TPSB2
NM_024164.6 missense

Scores

1
13

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -4.62

Publications

0 publications found
Variant links:
Genes affected
TPSB2 (HGNC:14120): (tryptase beta 2) Tryptases comprise a family of trypsin-like serine proteases, the peptidase family S1. Tryptases are enzymatically active only as heparin-stabilized tetramers, and they are resistant to all known endogenous proteinase inhibitors. Several tryptase genes are clustered on chromosome 16p13.3. These genes are characterized by several distinct features. They have a highly conserved 3' UTR and contain tandem repeat sequences at the 5' flank and 3' UTR which are thought to play a role in regulation of the mRNA stability. These genes have an intron immediately upstream of the initiator Met codon, which separates the site of transcription initiation from protein coding sequence. This feature is characteristic of tryptases but is unusual in other genes. The alleles of this gene exhibit an unusual amount of sequence variation, such that the alleles were once thought to represent two separate genes, beta II and beta III. Beta tryptases appear to be the main isoenzymes expressed in mast cells, whereas in basophils, alpha-tryptases predominate. Tryptases have been implicated as mediators in the pathogenesis of asthma and other allergic and inflammatory disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.081331134).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024164.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TPSB2
NM_024164.6
MANE Select
c.226G>Tp.Val76Leu
missense
Exon 3 of 6NP_077078.5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TPSB2
ENST00000606293.5
TSL:1 MANE Select
c.226G>Tp.Val76Leu
missense
Exon 3 of 6ENSP00000482743.1P20231
TPSB2
ENST00000612142.2
TSL:1
c.247G>Tp.Val83Leu
missense
Exon 2 of 5ENSP00000478695.1A0A087WUI4
TPSB2
ENST00000611196.4
TSL:1
n.226G>T
non_coding_transcript_exon
Exon 3 of 8ENSP00000484461.1A0A087X1U0

Frequencies

GnomAD3 genomes
Cov.:
18
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
1356528
Hom.:
0
Cov.:
36
AF XY:
0.00
AC XY:
0
AN XY:
668848
African (AFR)
AF:
0.00
AC:
0
AN:
29090
American (AMR)
AF:
0.00
AC:
0
AN:
32994
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21542
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36108
South Asian (SAS)
AF:
0.00
AC:
0
AN:
71962
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47960
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4188
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1056874
Other (OTH)
AF:
0.00
AC:
0
AN:
55810
GnomAD4 genome
Cov.:
18

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Uncertain
0.013
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
1.9
DANN
Benign
0.77
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.12
T
M_CAP
Benign
0.077
D
MetaRNN
Benign
0.081
T
MetaSVM
Benign
-0.91
T
PhyloP100
-4.6
PrimateAI
Benign
0.46
T
Sift4G
Benign
0.39
T
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

hg19: chr16-1279574; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.